The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
about
Endurance Exercise as an "Endogenous" Neuro-enhancement Strategy to Facilitate Motor LearningDNA modifications: function and applications in normal and disease StatesNeurotrophic factors as a therapeutic target for Parkinson's diseasePolygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory.Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients.Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responsesBDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory studyIsoprenoids, small GTPases and Alzheimer's disease.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell culturesEmerging roles of canonical TRP channels in neuronal function.Therapeutic concentrations of glucagon-like peptide-1 in cerebrospinal fluid following cell-based delivery into the cerebral ventricles of catsHumoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders.The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro.Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.BDNF Expression in Larval and Adult Zebrafish Brain: Distribution and Cell Identification.Identification of neurotoxic cytokines by profiling Alzheimer's disease tissues and neuron culture viability screening.Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapyTargeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro.Present and prospective clinical therapeutic regimens for Alzheimer's disease.Pgrmc1/BDNF Signaling Plays a Critical Role in Mediating Glia-Neuron Cross Talk.Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's DiseaseNeurotrophic factors in neurodegenerative disorders : potential for therapy.The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.Flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects.Impairments of synaptic plasticity in aged animals and in animal models of Alzheimer's diseaseTrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.De-repressing LncRNA-Targeted Genes to Upregulate Gene Expression: Focus on Small Molecule TherapeuticsRole of CREB in the regulatory action of sarsasapogenin on muscarinic M1 receptor density during cell aging.Filling the void: a role for exercise induced BDNF and brain amyloid precursor protein processing.Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Progress in the development of new drugs in Alzheimer's disease.Ca2+, CREB and krüppel: a novel KLF7-binding element conserved in mouse and human TRKB promoters is required for CREB-dependent transcriptionL-3-n-butylphthalide improves cognitive impairment of APP/PS1 mice by BDNF/TrkB/PI3K/AKT pathway.Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice.TUNEL and growth factor expression in the prefrontal cortex of Alzheimer patients over 80 years old.
P2860
Q26772814-49B5F64A-FA42-47AF-83F2-1B6BD6E674F0Q26829214-A16FF736-E20E-458D-8518-C906E9540524Q28273071-97AD333E-0A87-4CAC-8458-FC36975339F0Q33554988-6FEDAB3C-CC11-4064-9C7E-0F253BC9BEB9Q33728851-EB2A75F5-5D1B-449A-B03E-27A381FB5CD8Q33778336-0462F5E5-4CEE-45D5-BF15-085881E77E0AQ33854887-F2D56FFF-F472-480E-B65F-6D8F11D791ABQ33915441-47B8B4E6-B421-42CB-8438-C4E391AFFCDCQ34078777-9DFBDCD0-F71F-4CCA-BD42-99B91AE818F2Q34548310-20DFA8A5-44AD-4CF1-9CB4-54CF24CC70B0Q34610154-ACC485A9-41EA-43FB-83AE-B0838EA87A53Q35044628-AA2B5336-67BA-4738-A64C-D2A0626E51D8Q35082645-DB906203-45C7-46CF-84A0-FE67987E20D7Q35117516-0A159AED-7FE8-4AD5-9428-74D1856E5163Q35603915-2757E891-F889-4770-962E-EAAB2640431DQ36060174-79BA210B-6A32-4814-B751-C3088713BB50Q36275380-B3019D28-AABB-450D-A241-C7C3190AE9EEQ36708558-70ACE780-6C4B-4D14-BD6A-3F44AB1B8D49Q36725915-4F52C31A-82F7-494F-83C8-F0C7F5BD7DF0Q36876447-6736AD03-4E4E-4180-B6E1-813E83B3681DQ36911616-7063F989-E0BB-43B2-B26A-1E2A2495A692Q37314898-D6F85EF1-1AF5-4025-9925-A67F07D81DEBQ37322226-E1F2F8C3-C843-4346-BCE3-8F33F6482F62Q37728184-B5214B37-C3AB-49C2-BEC9-052F1EA33AE5Q37950344-B1EB94D6-7A0A-4E82-B659-91E5FC91CDC6Q37993230-4F73E7EB-BBDA-43B8-B158-56D220550D44Q38005423-1463E595-E7D8-474E-B632-F974BFEC2D47Q38106649-A25B974C-0066-41B7-BD63-A55FEED2FF5FQ38168376-F60935AB-971B-40EC-822F-1BBCAAFE1CF0Q38263685-C69F652B-4708-43DF-927F-9E65B51F54A0Q38269075-8D9FE08F-DBF4-48C4-BE2E-C11DB89602ACQ38345937-00B0466B-D91C-4657-A845-7EC780743775Q38641542-4F04DED3-DBC4-4FC5-BA27-DF2BEF0DAB7BQ38772566-D7ED9214-DD30-445E-AA75-F83B8A3067DDQ38999345-8DB43D7F-783E-4D7F-AF4C-BE2AC341729BQ39789745-E2A08BFB-32A7-405D-BDED-9A35E9044577Q41939307-F351007D-F546-446F-8697-0714EF4EDDB9Q41951765-F79D9B9B-A775-4372-97D5-7C3B6F356213Q42510029-27E3147D-44FF-4493-AE4B-FE1C2C07CBDCQ43105943-398A2AC3-3A35-479F-AD3C-DC1FD6B8C0C8
P2860
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@ast
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@en
type
label
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@ast
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@en
prefLabel
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@ast
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@en
P2093
P2860
P356
P1476
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
@en
P2093
P2860
P2888
P356
10.1038/SJ.TPJ.6500337
P577
2006-01-01T00:00:00Z
P5875
P6179
1048778615